Skip to content
Subscriber Only

Trump Treatment Thrusts Regeneron Virus Drug to Center Stage

  • Trump got experimental drug after compassionate use request
  • Regeneron reported promising trial results this week
Regeneron Begins Human Trials Of Coronavirus Antibody Cocktail
Photographer: Michael Nagle/Bloomberg

Regeneron Pharmaceuticals Inc. has found itself in the spotlight after President Donald Trump was treated with the company’s experimental antibody treatment for Covid-19, just days after the unveiling of promising preliminary trial results.

The Tarrytown, New York-based biotechnology company said it had provided a single high dose of the drug for Trump after receiving a compassionate-use request from his doctors. Trump is at higher risk of severe Covid-19 complications due to his age and clinical obesity.